₹225▲0.83%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 0.25 % |
3 Month Return | -5.46 % |
1 Year Return | + 108.26 % |
Market Stats | |
Previous Close | ₹223.15 |
Open | ₹228.95 |
Volume | 24.24K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹1,118.25Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹1,118.25 Cr |
P/B Ratio | 1.65 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹1,118.25 Cr | 53.04% | 0.51 | NA | NA |
![]() | NA | ₹2,794.56 Cr | 47.29% | 0.53 | ₹38 Cr | ₹1,417 Cr |
![]() | NA | ₹3,315.04 Cr | 1.4% | 0.74 | ₹67 Cr | ₹926 Cr |
![]() | BUY | ₹17,994.51 Cr | 16.49% | 0.50 | ₹308 Cr | ₹1,016 Cr |
![]() | NA | ₹49.49 Cr | -12.65% | 0.72 | ₹2 Cr | ₹68 Cr |
Organisation | Anuh Pharma Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Anuh Pharma Ltd
Anuh Pharma Ltd shares gained around 2% during the trading session, hitting a high of Rs. 235. The company's revenue increased by 15% from Rs. 150 crores to Rs. 172 crores in the December quarter, while net profits magnified by 36%. Anuh Pharma has delivered a multibagger of 165% to its investors in one year.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.03% in Mar 2024 quarter
Best in 1 Year
In the last 1 year, Anuh Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 70.9%
Promoter Holding Down
Promoters have decreased holdings from 69.94% to 69.92% in Mar 2024 quarter
Price Dip
In the last 3 months, Anuh Pharma stock has moved down by -5.5%
Retail Holding Down
Retail Investor have decreased holdings from 30.06% to 29.95% in Mar 2024 quarter
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹406.98Cr | ↑16.57% |
Total Liabilities | ₹165.75Cr | ↑22.47% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹53.90Cr | ↑86.76% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 69.92% | 0.00 | |
Foreign Institutions | 0.03% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 29.95% | 0.00 | |
Others | 0.11% | 0.00 |
Anuh Pharma Ltd’s net profit jumped 59.67% since last year same period to ₹15.36Cr in the Q4 2023-2024. On a quarterly growth basis, Anuh Pharma Ltd has generated -19.62% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Anuh Pharma Ltd has declared dividend of ₹2.50 - translating a dividend yield of 2.02%.
Read More about DividendsBearish
Neutral
Bullish
Anuh Pharma Ltd is currently in a Bearish trading position according to technical analysis indicators.
Anuh Pharma Ltd (506260) share price today is ₹225
Anuh Pharma Ltd is not listed on NSE
Anuh Pharma Ltd is listed on BSE
Today’s traded volume of Anuh Pharma Ltd(506260) is 24.24K.
Today’s market capitalisation of Anuh Pharma Ltd(506260) is ₹1118.25Cr.
Anuh Pharma Ltd(506260 | Price |
---|---|
52 Week High | ₹265 |
52 Week Low | ₹102.6 |
Anuh Pharma Ltd(506260) share price is ₹225. It is down -15.09% from its 52 Week High price of ₹265
Anuh Pharma Ltd(506260) share price is ₹225. It is up 119.30% from its 52 Week Low price of ₹102.6
Anuh Pharma Ltd(506260 | Returns |
---|---|
1 Day Returns | 1.85% |
1 Month Returns | 0.25% |
3 Month Returns | -5.46% |
1 Year Returns | 108.26% |